What does Tango Therapeutics, Inc. do?
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2…
What is Tango Therapeutics, Inc.'s P/E and P/B ratio?
Tango Therapeutics, Inc. has a P/E ratio of -32.9 and a P/B ratio of 4.60.
What is Tango Therapeutics, Inc.'s debt-to-equity ratio?
Tango Therapeutics, Inc. has a debt-to-equity ratio of 0.03.
How much does Tango Therapeutics, Inc. owe compared with what it owns?
Tango Therapeutics, Inc. owes $0.05 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Tango Therapeutics, Inc.'s Positivity rank?
Tango Therapeutics, Inc. is ranked #5,385 of 6,775 companies globally and #2,909 of 4,000 in United States on PositoAI, with a Positivity Score of 17,625.
Does Tango Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Tango Therapeutics, Inc..
Where can I read the latest news about Tango Therapeutics, Inc.?
Recent headlines about Tango Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Tango Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Tango Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.